Su appuntamento Martedi pomeriggio dalle 17 alle 19.
Prenotazioni tramite mail a andrea.mari@unifi.it
Ricercatore (RTDb) di Urologia (MED/24) presso il Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze. Attività clinico assistenziale c/o SOD Urologia Oncologica Mininvasiva Robotica ed Andrologica, AOU Careggi .
Expertise:
Specialista di chirurgia mini-invasiva robotica della patologia urinaria benigna e oncologica.
Laser terapia per ipertrofia prostatica benigna e calcolosi urinaria.
Esperto in terapia focale e trimodale con conservazione di organo per il trattamento del tumore prostatico e vescicale.
POSIZIONE ATTUALE:
TITOLI E POSIZIONI LAVORATIVE
Abilitazione scientifica nazionale a Professore di II fascia. Bando D.D. 1532/2016 settore concorsuale 06/E2. CHIRURGIA PLASTICA-RICOSTRUTTIVA, CHIRURGIA PEDIATRICA E UROLOGIA. Valido dal 19/08/2019 al 19/08/2025 (art. 16, comma 1, Legge 240/10).
Lingue
Membro di Boards a carattere scientifico nazionale ed internazionale: 4
Ruoli di Responsabilità per trial prospettici a carattere nazionale ed internazionale: 13
Revisore di riviste internazionali: 16
Revisore Abstracts a congressi nazionali e/o internazionali: 2
Editor di riviste internazionali: 6
Premi: 11
Numero di pubblicazioni effettuate:
IMPACT FACTOR:
ResearchEngine
Scopus(18-12-2023)
AuthorID
57205621894
Publicationyears
2014-2022
Papers
215
Cites/year
Cites/paper
TotalCitations
2477
Hirsch(H)index
31
g-index
40
hI,norm
29
hI,Annual
Firenze, 20/12/2023
Legenda
Current Position:- Researcher (RTDb) in Urology (MED/24) at the Department of Experimental and Clinical Medicine, University of Florence.- Clinical and care activities at the Division of Minimally Invasive Robotic and Andrological Oncological Urology, AOU Careggi.
Expertise:- Specialist in robotic minimally invasive surgery for benign and oncological urinary pathology.- Laser therapy for benign prostatic hyperplasia and urinary calculi.- Expert in focal and trimodal therapy with organ preservation for the treatment of prostate and bladder cancer.
Titles and Employment Positions:- Degree in Medicine and Surgery, with honors (110/110) from the University of Florence. Thesis: "Robotic enucleation of renal masses ≤7cm (cT1): comparison with open technique based on surgical and functional results. (Prospective monocentric study)." Advisor: Prof. Marco Carini.- Registered with the Provincial Medical Association of Florence (Registration Number 13464).- Specialization in Urology from the University of Florence with honors (70/70).- Research fellowship in oncological urology at the Comprehensive Cancer Center, University of Vienna, Austria. Tutor: Prof. Shahrokh F. Shariat.- Research Fellowship in oncological urology at the Lunenfeld Tanenbaum Research Institute - Mount Sinai Hospital - Toronto, Canada. Tutor: Prof. Alexandre Zlotta.- PhD in Clinical Sciences from the Department of Experimental and Clinical Medicine, University of Florence, with highest honors and special mention. Clinical activities at the Division of Minimally Invasive Robotic and Andrological Oncological Urology, AOU Careggi.- National scientific qualification as an Associate Professor. Announcement D.D. 1532/2016 in the competitive sector 06/E2. PLASTIC-RECONSTRUCTIVE SURGERY, PEDIATRIC SURGERY, AND UROLOGY. Valid from 08/19/2019 to 08/19/2025 (art. 16, paragraph 1, Law 240/10).- Research grant under article 22 of law 240/2010 at the Department of Experimental and Clinical Medicine. Type 3 (independent clinical activity). Responsible: Prof. Andrea Minervini. Project Title: "Analysis of postoperative outcomes in patients treated with partial nephrectomy and ablative therapies for kidney tumors: Unified collection of prospective observational studies RECORD 2 (The Italian Registry of Conservative and Radical surgery for cortical renal tumor Disease) and EuRECA (European Registry for Renal CryoAblation)".- Researcher (RTDb) in Urology (MED/24) at the Department of Experimental and Clinical Medicine, University of Florence with clinical responsibilities as Medical Director at the Division of Minimally Invasive Robotic and Andrological Oncological Urology, AOU Careggi.
Languages:- Italian (Native).- English (C1 Level).- Spanish Castilian (C2 Level).
Member of National and International Scientific Boards: 4- Member of the Resources and Communication Office directed by Prof. Vincenzo Mirone of the Italian Society of Urology from January 2019 to November 2021. Activities included scientific communication and promotion of urological health among society members and the general population.- Member of the "Young Academic Urologists" panel - Urothelial Carcinoma Working Group within the European Association of Urology (EAU) from November 2019 to present. Activities focus on scientific production in major European centers on urothelial carcinoma.- Member of the "Stop sMoking for Advance Rehabilitation Treatments" (SMART) - Urology Working Group since April 2019. The international group aims to promote rehabilitative activities for tobacco smoking cessation in patients with urological neoplasms. Coordinators: Giovanni Cacciamani, Michael Rink. Members: Matulewicz RS, Kumar R, Teoh JY, Mari A, Pradere B, Gomez Rivas J, Necchi A, Kumar Pal S, Ribal MJ, Shariat SF.- Member of the Research Office directed by Prof. Andrea Minervini of the Italian Society of Urology since January 2022. The office promotes scientific activity involving member centers of the Italian Society of Urology. Notably, the group is coordinating projects such as i-RECORd (Italian and international multicenter study on the management of kidney tumors), SIU Research Web Benign (National registry of ultra-minimally invasive therapies for BPH), SIU Research Web Onco (National registry for the treatment of prostate, upper urinary tract, testicular, and penile tumors), Italian Urology Researchers in Surgical Training (IURST), and a multidisciplinary working group on the economic impact of robotic minimally invasive surgery in Italy.
Roles of Responsibility in National and International Prospective Trials: 13
Sub-investigator Role at AOU Careggi, Florence, assigned by Janssen Research & Development LLC for clinical trial No. NCT03767244: "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy."
Principal Investigator for Careggi Urology Clinic in RECORD 1 Study: An observational study of conservative renal surgery in Italy using open, laparoscopic, and robot-assisted approaches from 2008 to 2011 (19 centers included). This project gathered data from about 800 patients undergoing surgical treatment.
Principal Investigator for Careggi Urology Clinic in RECORD 2 Study: An observational study of renal surgery in Italy. Radical nephrectomy and conservative renal surgery, open, laparoscopic, and robot-assisted (26 centers included). This project gathered data from about 4300 patients undergoing surgical treatment.
Role in Protocol Writing and Steering Committee Member for the International prospective observational REgistry of Conservative or Radical treatment of localized kiDney tumors (i-RECORD) Project. This longitudinal, non-interventional epidemiological observational study aims to analyze surgical results and 24-month oncological-functional follow-up of patients undergoing conservative and radical surgery for localized kidney tumors in 35 high-volume international centers since January 2020. This study recently received a 40,000 euro grant from the Italian group for advanced laparo-endoscopic and robotic urological surgery (AGILE) and a 50,000 euro grant from the Italian Society of Urology.
Principal Researcher alongside Prof. Alexandre Zlotta (Department of Urologic Oncology, UHN Toronto), and Prof. Peter Chung (Department of Radiation Oncology, UHN Toronto) in a multicentric, retrospective, observational project comparing oncological outcomes of patients undergoing radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer (cT2-3N0M0) from January 2012 to December 2016. Centers involved: The University Health Network (UHN) Toronto (Prof. Alexandre Zlotta); Massachusetts General Hospital, University of Harvard (Prof. Jason A. Efstathiou); University of Florence (Prof. A. Minervini). The results of this project were discussed at the ASCO GU 2022 Symposium (DOI: 10.1200/JCO.2022.40.6_suppl.433).
Principal Investigator for the international "UTUC Collaboration" project. This project gathered data from over 1200 patients treated for upper tract tumors in 15 European and North American centers.
Investigator for Careggi Urology Clinic in the ROBUUST (ROBotic surgery for Upper tract Urothelial cancer STudy) Project. This project analyzed data from over a thousand patients undergoing nephroureterectomy for upper tract carcinoma in high-volume European and North American centers.
Investigator for Careggi Urology Clinic in the REMARCC (REgistry for MetAstatic RCC) Project. This project gathered over a thousand patients who underwent cytoreductive nephrectomy for metastatic kidney cancer in European centers.
Investigator at AOU Careggi, Florence, assigned by Elypta SPA for the international prospective study "AUR87A: Glycosaminoglycan scores for surveillance of recurrence in Leibovich points ≥5 non-metastatic clear cell renal cell carcinoma".
Investigator at AOU Careggi, Florence, assigned by Elypta SPA for the international prospective study "AUR93A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study".
Principal Investigator for the SMART (Stop sMoking for Advance Rehabilitation Treatments) Urology Working Group. This group developed systematic reviews on the association of smoking with increased incidence of urological neoplasms and worse outcomes after treatment. The group also developed rehabilitation proposals for smoking cessation after the diagnosis of uro-oncological pathology.
Principal Investigator and Coordinator within the SIU (Italian Society of Urology) Research Web Onco for the National Registry of the Treatment of Upper Tract Carcinoma. This prospective, multicentric Italian observational study aims to enroll patients treated from November 2022 to December 2023.
Principal Investigator within the SIU (Italian Society of Urology) Italian Urology Researchers in Surgical Training (IURST) Research Collaborative group. This group aims to promote and coordinate research activities on surgical training methods by medical specialists in training in urology who are members of the SIU.
Number of Publications:
